Acute Myeloid Leukemia (AML) During Pregnancy: Understanding the Risks and Management

Understanding Acute Myeloid Leukemia (AML) in Pregnancy

Acute Myeloid Leukemia (AML) is a type of cancer that affects the blood and bone marrow. While it is more commonly diagnosed in older adults, it can, in rare instances, occur during pregnancy. This condition is serious and requires prompt medical attention for both the pregnant individual and the developing fetus. This article aims to provide comprehensive information about AML in pregnancy, tailored for an Indian audience, covering its rarity, symptoms, diagnostic challenges, treatment options, and potential impacts on the pregnancy and newborn.

What is Acute Myeloid Leukemia (AML)?

Leukemia is a cancer of the blood-forming tissues, including bone marrow and the lymphatic system. AML is one of the four main types of leukemia. It is classified as 'acute' because it progresses rapidly and 'myeloid' because it originates from myeloid cells in the bone marrow. These myeloid cells are responsible for producing red blood cells, platelets, and certain types of white blood cells. In AML, these cells develop abnormally, multiply uncontrollably, and crowd out healthy blood cells. This disruption can lead to various health complications.

Rarity of AML in Pregnancy

AML is a relatively rare cancer overall, accounting for about 1% of all cancers in adults. The average age of diagnosis for AML is around 68 years, making it uncommon in younger adults, particularly those in their childbearing years. The incidence of any leukemia during pregnancy is estimated to be between 1 in 75,000 to 100,000 pregnancies. AML constitutes about two-thirds of these pregnancy-related leukemia diagnoses. This rarity means that healthcare providers may not always consider it as a primary diagnosis, especially when symptoms overlap with normal pregnancy changes.

Symptoms of AML During Pregnancy

The symptoms of AML arise from the bone marrow's inability to produce sufficient healthy blood cells. These symptoms can be insidious and may be mistaken for common pregnancy discomforts, potentially delaying diagnosis. Key symptoms include:

• Anemia (Low Red Blood Cell Count): This can manifest as persistent fatigue, extreme weakness, shortness of breath, dizziness, lightheadedness, headaches, and pale skin. Pregnant individuals often experience fatigue, making it difficult to distinguish from AML-induced tiredness.
• Increased Risk of Infections (Low White Blood Cell Count): A compromised immune system due to low white blood cells makes the individual more susceptible to infections. Frequent or severe infections could be a warning sign.
• Easy Bleeding or Bruising (Low Platelet Count): Reduced platelet levels can lead to spontaneous bruising, prolonged bleeding from minor cuts, nosebleeds, or bleeding gums. In pregnant individuals, this can also manifest as unusual vaginal bleeding.
• Other potential symptoms: Fever, chills, loss of appetite, weight loss, bone pain, and swollen lymph nodes can also occur.

Diagnostic Challenges

Diagnosing AML during pregnancy presents unique challenges. The overlap in symptoms with normal pregnancy changes is a significant hurdle. Furthermore, certain diagnostic procedures, like bone marrow biopsies, need careful consideration due to potential risks to the pregnancy. However, timely diagnosis is crucial for effective treatment. The diagnostic process typically involves:

• Blood Tests: Complete Blood Count (CBC) to assess levels of red blood cells, white blood cells, and platelets.
• Bone Marrow Biopsy and Aspiration: This is the definitive diagnostic test, where a sample of bone marrow is extracted and examined for the presence and type of leukemia cells.
• Imaging Tests: May be used to check for spread to other organs.
• Genetic Testing: To identify specific mutations in leukemia cells, which can help in treatment planning.

Impact on Pregnancy and Fetus

AML during pregnancy poses risks to both the mother and the fetus. The cancer itself can affect fetal development and increase the risk of complications. Chemotherapy, a primary treatment for AML, also carries risks, especially during the first trimester when the fetus is most vulnerable to congenital defects. Potential impacts include:

• Increased risk of miscarriage or fetal death.
• Congenital abnormalities in the baby if chemotherapy is administered during early pregnancy.
• Premature birth.
• Increased risk of infections for the newborn after delivery.

The timing of diagnosis within the pregnancy is also a factor. Studies show that AML diagnoses occur across trimesters: approximately 23% in the first trimester, 37% in the second, and 40% in the third.

Treatment of AML During Pregnancy

The treatment of AML during pregnancy is complex and requires a multidisciplinary approach involving oncologists, hematologists, and obstetricians. The primary goal is to treat the leukemia while minimizing risks to the fetus. Treatment strategies depend on several factors, including the stage of AML, the trimester of pregnancy, and the overall health of the mother and fetus.

• Chemotherapy: This is the cornerstone of AML treatment. Certain chemotherapy drugs are considered relatively safer during the second and third trimesters. The decision to start chemotherapy, the choice of drugs, and the dosage are carefully weighed against potential risks.
• Timing of Delivery: If the pregnancy is advanced (beyond 32 weeks) and the individual is diagnosed with AML, doctors might recommend delivering the baby before starting aggressive chemotherapy. This allows the baby to be born in a more stable condition and enables the mother to receive more intensive treatment.
• Supportive Care: This includes blood transfusions to manage anemia and low platelet counts, and antibiotics to prevent or treat infections.
• Stem Cell Transplant: While a potential cure for AML, this is generally not considered during pregnancy due to its intensity and risks.

A review of published data between 1969 and 2014, which included 85 fetuses from 83 individuals diagnosed with AML during pregnancy and treated with chemotherapy, indicated that delivery of a healthy baby is the most common outcome, despite the risks associated with treatment.

When to Consult a Doctor

It is crucial for pregnant individuals to consult their doctor or obstetrician immediately if they experience any persistent or unusual symptoms, such as:

• Unexplained and severe fatigue or weakness.
• Shortness of breath that is not typical for pregnancy.
• Easy bruising or bleeding, including unusual vaginal bleeding.
• Frequent or severe infections.
• Unexplained weight loss or loss of appetite.

Early detection and intervention are key to improving outcomes for both the mother and the baby.

Prevention

Currently, there are no specific preventive measures for AML, as its causes are not fully understood and it can occur spontaneously. However, maintaining a healthy lifestyle during pregnancy, including a balanced diet and regular, moderate exercise as advised by your doctor, can support overall health and well-being.

Frequently Asked Questions (FAQ)

1. Can a baby be born with AML?

   While extremely rare, a condition called congenital leukemia can occur if leukemia cells are transmitted from the mother to the fetus. However, AML in the mother does not automatically mean the baby will develop leukemia. The risks are carefully managed by the medical team.

2. Is AML during pregnancy treatable?

   Yes, AML during pregnancy is treatable. The treatment plan is individualized to balance the mother's health and the baby's development, often involving chemotherapy and careful monitoring.

3. Can chemotherapy during pregnancy harm the baby?

   Chemotherapy can pose risks to the developing fetus, particularly in the first trimester. However, certain chemotherapy regimens are considered safer in the second and third trimesters, and the medical team will choose the least harmful options and monitor the pregnancy closely.

4. What is the outlook for AML during pregnancy?

   The outlook varies depending on several factors, including the specific type of AML, the stage of the cancer, the mother's overall health, and the timing of treatment. However, with advancements in medical care and a multidisciplinary approach, many individuals achieve remission and deliver healthy babies.

Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.